Gene Knock-In Techniques

"Gene Knock-In Techniques" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
Techniques used to add in exogenous gene sequence such as mutated genes; REPORTER GENES, to study mechanisms of gene expression; or regulatory control sequences, to study effects of temporal changes to GENE EXPRESSION.


expand / collapse Publications
This graph shows the total number of publications written about "Gene Knock-In Techniques" by people in this website by year, and whether "Gene Knock-In Techniques" was a major or minor topic of these publications.
Below are the most recent publications written about "Gene Knock-In Techniques" by people in Profiles.
  1. Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis. J Exp Med. 2025 Jan 06; 222(1).
    View in: PubMed
  2. Phosphatidylserine phospholipase A1 enables GPR34-dependent immune cell accumulation in the peritoneal cavity. J Exp Med. 2024 Nov 04; 221(11).
    View in: PubMed
  3. Influence of Th1 versus Th2 immune bias on viral, pathological, and immunological dynamics in SARS-CoV-2 variant-infected human ACE2 knock-in mice. EBioMedicine. 2024 Oct; 108:105361.
    View in: PubMed
  4. Establishment and characterization of an hACE2/hTMPRSS2 knock-in mouse model to study SARS-CoV-2. Front Immunol. 2024; 15:1428711.
    View in: PubMed
  5. Affinity gaps among B cells in germinal centers drive the selection of MPER precursors. Nat Immunol. 2024 Jun; 25(6):1083-1096.
    View in: PubMed
  6. Sex-specific associations between AD genotype and the microbiome of human amyloid beta knock-in (hAβ-KI) mice. Alzheimers Dement. 2024 07; 20(7):4935-4950.
    View in: PubMed
  7. Variant-specific in vitro neuronal network phenotypes and drug sensitivity in SCN2A developmental and epileptic encephalopathy. J Neurochem. 2024 Dec; 168(12):3950-3961.
    View in: PubMed
  8. Non-viral precision T cell receptor replacement for personalized cell therapy. Nature. 2023 03; 615(7953):687-696.
    View in: PubMed
  9. Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4. Nature. 2022 06; 606(7916):945-952.
    View in: PubMed
  10. Improving the efficiency of CRISPR-Cas12a-based genome editing with site-specific covalent Cas12a-crRNA conjugates. Mol Cell. 2021 11 18; 81(22):4747-4756.e7.
    View in: PubMed